A BCL-X-L PROTAC degrader DT2216 synergizes with KRAS(G12C) inhibitors for effectively treating KRAS(G12C)-mutated cancers.
CANCER RESEARCH(2022)
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined